VOLT CE Mark Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 300 participants.

Also called NCT06106594

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06106594
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Australia, Austria, Belgium, Czechia, Germany, Netherlands, Spain (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06106594. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-24 (actual); primary completion 2027-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
VOLT CE Mark Study
Condition
Atrial Arrhythmia
Condition
Paroxysmal Atrial Fibrillation
Condition
Persistent Atrial Fibrillation
Intervention (Device)
Pulsed Field Ablation
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct06106594
Content hash
ea941d6677c38444c9433eab7da731a8ffd4968347b79110c5937387a2c1df33